NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 54 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $17,000 | – | 13,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|